April 2020: an ambulance picks up a possible covid patient near Liège. Whether the pill really makes a difference – and thus reduces the risk of hospitalization – will be known in September or October. — © afp
The drug company Merck is investigating whether molnupiravir can prevent the first symptoms from derailing into severe covid-19. It is one of the few drugs in the pipeline to avoid hospital admissions.
Read Also
- Aceti (Salutequità): “Only 32% family doctors issue digital prescriptions” Jul 24, 2021
- US sent two million doses of coronavirus vaccine to Ukraine Jul 16, 2021
- Covid, 500 sites spread hoaxes about viruses and vaccines Sep 8, 2021
- Covid-19: In China, the strong anger of the Cantonese after a new confinement Nov 15, 2022
- Jalisco. Health sector workers demand job relocation Jul 10, 2021
- Heatwaves and Covid-19: Health authorities estimate the excess number of deaths in France this summer at 10,420 Nov 22, 2022
- Panguipulli: dialysis patients accuse mistreatment by the driver who takes them to their homes Nov 16, 2022
Maxie Eckert
Today at 11:34 AM
.
